Esperion Therapeutics' net profit under GAAP for 6 months of 2020 was $46,362 million, up 39.8% from $33,158 million the previous year. Revenue increased 46.2% to $214,076 million from $146,401 million a year earlier.
Esperion Therapeutics' net profit under GAAP for 6 months of 2020 was $46,362 million, up 39.8% from $33,158 million the previous year. Revenue increased 46.2% to $214,076 million from $146,401 million a year earlier. 
esperion.gcs-web.com
English (US) 